Satellite Banner
Technology Networks Header
Monday, December 22, 2014
 
Register | Sign in
Home Page>Products
  Product News
Consistent Embryoid Body Formation and Differentiation from Stem Cells
Tuesday, December 02, 2014
Cultrex® Embryoid Body Formation Kit from AMSBIO.

Sophisticated HIV Diagnostics Adapted for Remote Areas
Tuesday, December 02, 2014
New tool is low-cost, with no electricity needed - NIH study.

SYGNIS Presents its First Own Product Line: TruePrime™
Tuesday, December 02, 2014
TruePrime™ revolutionizes whole genome and transcriptome amplification.

ZEISS Presents New Stereo Microscopes
Tuesday, December 02, 2014
Capture images, document and share results with ZEISS Stemi 305 and ZEISS Stemi 508.

Improving Sub-Ambient Reaction Reproducibility
Tuesday, December 02, 2014
The DrySyn Snowstorm MULTIfrom Asynt provides a simple and highly effective way to perform multiple reactions in parallel across a large temperature range including sub-ambient chemistries such as organometallic syntheses and controlled rate crystallisation studies down to -60°C.

BioTek Introduces 2nd Generation Cytation Imaging Reader
Tuesday, December 02, 2014
New Cytation™ 5 Cell Imaging Multi-Mode Reader enhance phenotypic cellular information and well-based quantitative data.

Sysquant® Awarded Two Contracts
Monday, December 01, 2014
Proteome Sciences provide an update on SysQuant ®, its phosphorylation assay that provides insight into normal cell function, disease state and response to drug treatments in patients.

OSU Launches NGS Cancer Panels Using GO Clinical Workbench
Friday, November 28, 2014
Company’s GO Clinical Workbench™ to enable clinical reporting of mutations detected from NGS.

New Application Note from Malvern Instruments
Thursday, November 27, 2014
Application note shows value of Nanoparticle Tracking Analysis in exosome studies.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 10725
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn